Propanc Biopharma Says Preclinical PRP Data In Pancreatic Cancer Models Showed Greater Than 90% Mean Tumor Growth Inhibition, More Than 2.5-Fold Median Survival Extension
Share
Why It Matters
A small medicine company tested a new cancer treatment in lab models, and it shrank tumors and helped them survive longer. This is early-stage research, so we watch to see if it works safely in real people next.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.